PPAR調節因子

Japanese Patent JP2007502815

A

The present invention is directed to a compound of formula I, or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.

Isabel Christina Gonzalez Barcarcel
Nathan Bryan Mantro
Kin Shi
One Min Min
Leonard Larry Wineroski Jr.
Shu Yampin
Jeremy Schulenberg York

JP2006523861A

February 15, 2007

August 17, 2004

Click for automatic bibliography generation  

Eli Lilly and Company

C07C59/68; A61K31/095; A61K31/155; A61K31/185; A61K31/192; A61K31/195; A61K31/341; A61K31/343; A61K31/357; A61K31/381; A61K31/40; A61K31/405; A61K31/421; A61K31/423; A61K31/426; A61K31/44; A61K31/4402; A61K31/4418; A61K31/444; A61K31/47; A61K31/472; A61K31/505; A61K31/616; A61K31/64; A61K38/28; A61K45/00; A61K45/06; A61P1/14; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P9/04; A61P9/12; A61P25/00; A61P43/00; C07C59/72; C07C59/90; C07C61/39; C07C69/732; C07C217/80; C07C251/40; C07C251/48; C07C317/22; C07C323/20; C07C323/52; C07C323/62; C07D207/333; C07D209/42; C07D213/30; C07D213/50; C07D213/64; C07D213/69; C07D213/74; C07D215/20; C07D217/02; C07D239/26; C07D261/20; C07D263/14; C07D263/32; C07D277/24; C07D307/42; C07D307/79; C07D307/80; C07D319/18; C07D333/16; C07D333/22; C07D333/56

JP2002503202A

2002-01-29

Kyousei Tamura
Minato Saito
Nagatoshi Shinagawa

Previous Patent: パーフルオロポリエーテルアミド連結ホスホネート、ホスフェートおよび�...

Next Patent: グルカゴン様ペプチド（ＧＬＰ）−１化合物またはメラノコルチン４受容�...